无惧减肥药冲击！可口可乐CEO：不至于威胁到我们_老虎社区_美港股上老虎

无惧减肥药冲击！可口可乐CEO：不至于威胁到我们

华尔街见闻01-19

可口可乐首席执行官詹姆斯·昆西表示，如果减肥药风靡造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要组成部分。Ozempic和Wegovy等减肥药近期可谓火爆，可口可乐首席执行官詹姆斯·昆西（James Quincey）周四在达沃斯论坛上表示，如果这些药品造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2404529165?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/e13126ac9635b8568d0259ee11c4f36e","is_english":false,"pubTime":"2024-01-19 03:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2404529165","market":"us","top_or_hot":-1,"title":"无惧减肥药冲击！可口可乐CEO：不至于威胁到我们","media":"华尔街见闻","content":"<div>\n<p>可口可乐首席执行官詹姆斯·昆西表示，如果减肥药风靡造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要组成部分。Ozempic和Wegovy等减肥药近期可谓火爆，可口可乐首席执行官詹姆斯·昆西（James Quincey）周四在达沃斯论坛上表示，如果这些药品造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3706706\">网页链接</a>\n\n</div>\n","source":"wallstreetcn_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>无惧减肥药冲击！可口可乐CEO：不至于威胁到我们</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n无惧减肥药冲击！可口可乐CEO：不至于威胁到我们\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-19 03:44 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wallstreetcn.com/articles/3706706><strong>华尔街见闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>可口可乐首席执行官詹姆斯·昆西表示，如果减肥药风靡造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要组成部分。Ozempic和Wegovy等减肥药近期可谓火爆，可口可乐首席执行官詹姆斯·昆西（James Quincey）周四在达沃斯论坛上表示，如果这些药品造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要...</p>\n\n<a href=\"https://wallstreetcn.com/articles/3706706\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BLSP4452.SGD","symbol_name":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","start_time":0,"source_url":"https://wallstreetcn.com/articles/3706706","article_id":"2404529165","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/e13126ac9635b8568d0259ee11c4f36e"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3706706","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2404529165","pubTimestamp":1705607097,"sourceInfo":{"source_id":"wallstreetcn_hot_news","name":"华尔街见闻"},"weMediaInfo":null,"summary":"可口可乐首席执行官詹姆斯·昆西表示，如果减肥药风靡造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要组成部分。","collect":0,"end_time":0,"defaultTopTitle":"wallstreetcn.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","KO":"可口可乐","SG9999014575.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USDHDG) INC","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","LU2360032135.SGD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (SGDHDG) INC","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","LU1732800096.USD":"摩根大通环球收益基金A (irc)","LU1670710588.SGD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (SGD) ACC","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","LU1670710661.SGD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (SGD) INC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU0061474960.USD":"天利环球焦点基金AU Acc","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4588":"碎股","SG9999002232.USD":"Allianz Global High Payout USD","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU1670711123.USD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (USD) INC","SG9999002224.SGD":"Allianz Global High Payout SGD","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU2279689827.SGD":"JPMorgan Investment Funds - Global Income Sustainable A (mth) SGD-H","SG9999014559.SGD":"United Income Focus Trust Dis SGD","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","BK4581":"高盛持仓","SG9999014567.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USD) ACC","LU1670711040.USD":"M&G (LUX) GLOBAL DIVIDEND \"A\" (USD) ACC","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","SG9999015358.SGD":"United Income Focus Trust Dis SGD-H","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","SG9999015341.SGD":"United Income Focus Trust Acc SGD-H","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","BK4532":"文艺复兴科技持仓","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H"},"translate_title":"Fear the impact of diet pills! Coca-Cola CEO: Not a threat to us","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/41aa6a84220f0a9e9c021eed3c9a4912","symbols_score_info":{"KO":1},"content_text":"可口可乐首席执行官詹姆斯·昆西表示，如果减肥药风靡造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要组成部分。Ozempic和Wegovy等减肥药近期可谓火爆，可口可乐首席执行官詹姆斯·昆西（James Quincey）周四在达沃斯论坛上表示，如果这些药品造成消费者习惯的变化，该公司的多种产品将能够保护业务，并表示原版可乐类饮料仍将是公司业务的重要组成部分。诺和诺德（Novo Nordisk A/S）和礼来（Eli Lilly & Co.）等药厂出品的各类GLP-1糖尿病药物，目前被消费者越来越多地用于减肥和抑制食欲等目的。作为以碳酸饮料为主要产品的厂商，昆西表示，在各类饮料产品中，无论是在碳酸饮料、果汁还是运动饮料等类别，可口可乐都有含糖和无糖的产品，“我们已经有了可以应对消费者行为转变的产品。”“当你分析数据时，我认为这对我们来说不是一件大事，”他说。“我们销售的饮料多种多样，如果要简化到极点，你可以减少摄入的热量，但最终还是无法减少液体的摄入。”目前，从零售商到包装食品制造商，消费品公司正在考虑如何将减肥药使用率飙高这一因素纳入战略考量，此前一些分析师预测了减肥药给零食和饮料公司带来的风险。至于原版的含糖可乐饮料，昆西表示：“我认为它将继续是业务的重要组成部分。”他还说，巴以冲突期间，以色列和加沙的可口可乐装瓶厂员工出现伤亡，公司的主要关注点是在冲突期间帮助员工，昆西表示没有退出该地区的计划。“我们的业务是在每个国家开展业务，”他说，所有政治领导人都希望本地所有的装瓶厂创造就业机会。可口可乐股价周四开盘走低，盘中收复所有跌幅，报60美元。","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}